Contagion&reg Editorial Staff

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of November 24, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

As November draws to a close, the Contagion® editorial team is recapping the trends and top infectious disease news of the month.

Timothy Ray Brown, also known as the "Berlin Patient" discusses why it's important to push out the message that U=U.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of November 17, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Pamela Gorman, RN, ACRN, discusses how electronic health data and coordinated outreach can be combined to increase retention in care.

In 2010, Timothy Ray Brown came forward as the "Berlin Patient" and has become an advocate for people living with HIV. He hopes to see the day when all individuals when HIV can be cured safely.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of November 10, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

The FDA has cleared for marketing the first duodenoscope with a sterile, disposable elevator component that will reduce the number of parts that need to be cleaned and disinfected (reprocessed) in between uses.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Jennifer Cocohoba, PharmD, summarizes her ANAC 2019 presentation on polypharmacy and how it affects people living with HIV.

Cefiderocol has been approved for the treatment of complicated urinary tract infections (cUTI), including kidney infections caused by susceptible gram-negative microorganisms, who have limited or no alternative treatment options. Labeling includes a warning regarding the higher all-cause mortality rate in the CREDIBLE-CR study.

In an interview at ANAC 2019, Shameka L. Cody, PhD, AGNP-C, discusses the impact of cognitive training on quality of life outcomes for people with HIV-associated neurocognitive disorder.

Timothy Ray Brown, formerly known as the “Berlin Patient” explains why it is important for providers to form relationships with patients and avoid stigma and judgment.

Brian Minalga, MSW, discusses research on the historical exclusion of women in HIV cure-related research.

Julie Zuñiga, PhD, RN, shares findings from her research on self-management of the dual diagnosis of HIV and diabetes.

Rasheeta Chandler, PhD, RN, emphasizes including of black women in efforts to end the HIV epidemic and discusses an app she is developing to help women access information about sexual health.

Timothy Ray Brown is the first person to ever be cured of HIV. He discusses his decision to no longer remain anonymous and why he shares his story with the world.

Here is a look at infectious disease-related US Food and Drug Administration (FDA) news from the week of November 3, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

A recent study suggests that smokers living with HIV were willing to transition to electronic cigarettes and had lower carbon monoxide levels after doing so.

The FDA has authorized marketing of the Sentosa SQ HIV Genotyping Assay, which detects HIV-1 mutations in patients undergoing or about to initiate antiviral treatment.

The Contagion® editorial staff will be providing exclusive written and video coverage from ANAC 2019.

Fluzone High-Dose Quadrivalent is given to people 65 years of age and older to help prevent influenza disease caused by influenza A and B strains contained in the vaccine.

RHB-105 (Talicia) is the only rifabutin-based therapy approved for the treatment of H pylori infection and is designed to address the high resistance of H pylori bacteria to current clarithromycin-based standard-of-care therapies.